111 related articles for article (PubMed ID: 32433403)
1. Establishment of a 7-miRNA-Based Risk Score System for Predicting Prognosis of Pancreatic Cancer.
Zhuang H; Ma Z; Huang K; Zhou Z; Huang B; Sun Z; Hou B; Zhang C
Pancreas; 2020; 49(5):655-662. PubMed ID: 32433403
[TBL] [Abstract][Full Text] [Related]
2. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
Tang J; Ma W; Zeng Q; Tan J; Cao K; Luo L
Dis Markers; 2019; 2019():3815952. PubMed ID: 31976020
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
4. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
5. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
6. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
7. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
8. Development of a 12-biomarkers-based prognostic model for pancreatic cancer using multi-omics integrated analysis.
Jia Y; Shen M; Zhou Y; Liu H
Acta Biochim Pol; 2020 Dec; 67(4):501-508. PubMed ID: 33253517
[TBL] [Abstract][Full Text] [Related]
9. A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.
Shi XH; Li X; Zhang H; He RZ; Zhao Y; Zhou M; Pan ST; Zhao CL; Feng YC; Wang M; Guo XJ; Qin RY
Sci Rep; 2018 May; 8(1):7638. PubMed ID: 29769534
[TBL] [Abstract][Full Text] [Related]
10. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
Jin X; Guan Y; Zhang Z; Wang H
BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
[TBL] [Abstract][Full Text] [Related]
11. An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.
Yi W; Liu J; Qu S; Fan H; Lv Z
Technol Cancer Res Treat; 2020; 19():1533033820965594. PubMed ID: 33054579
[TBL] [Abstract][Full Text] [Related]
12. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
14. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
15. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
[TBL] [Abstract][Full Text] [Related]
16. Five miRNAs considered as molecular targets for predicting neuroglioma.
Yang H; Wang Y
Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
[TBL] [Abstract][Full Text] [Related]
17. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
Dou D; Yang S; Lin Y; Zhang J
Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
[TBL] [Abstract][Full Text] [Related]
18. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics prediction and experimental validation of a novel microRNA: hsa-miR-B43 within human CDH4 gene with a potential metastasis-related function in breast cancer.
Rahimi A; Sedighi R; Emadi-Baygi M; Honardoost MA; Mowla SJ; Khanahmad H; Nikpour P
J Cell Biochem; 2020 Feb; 121(2):1307-1316. PubMed ID: 31489987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
